Startseite Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients

  • Dhani Wijaya , Elfri Padolo , Chrismawan Ardianto , Sumarno , Fendy Matulatan , Chris Alderman und Suharjono EMAIL logo
Veröffentlicht/Copyright: 11. Januar 2020
Journal of Basic and Clinical Physiology and Pharmacology
Aus der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology Band 30 Heft 6

Abstract

Background

Stress ulcer is a superficial and asymptomatic lesion and causes bleeding. As many as 50% of death cases are reported as the result of stress ulcer bleeding. Stress ulcer prophylaxis (SUP) is a drug used to prevent gastrointestinal tract injuries due to stress ulcers. The inappropriate use of SUP drugs can cause adverse drug reactions, and thus SUP drugs are only given to patients in accordance with guidelines in order to avoid the overuse of SUP drugs. The aim of this present study is to analyse the suitability of SUP drug usage based on the criteria from the American Society of Health-System Pharmacists (ASHP) and the drug costs of SUP overuse.

Methods

An observational descriptive study was conducted from April 24, 2019, to May 17, 2019, in the inpatient surgical ward of Dr. Soetomo General Hospital. Data were obtained from patient medical health records.

Results

One hundred fifty-two patients used 1404 SUP drugs. Approximately 48% of usage did not suit the ASHP criteria and was considered as medication overuse. The cost of excessive SUP usage during the study period was more than US $65, which is 30.08% of the total drug cost of prescribed stress ulcer drugs.

Conclusions

The present study suggests that the relatively high excessive drug costs for SUP show a need for monitoring of the application of SUP therapy guidelines.

Keywords: drug costs; overuse; stress ulcer; stress ulcer prophylaxis

Acknowledgements

Gratitude is due to the director and the head of the Inpatient Operating Room of Dr. Soetomo General Hospital.

  1. Research funding: We thank to Tahir Foundation professorship program (Dr. Suharjono) for supporting the study.

  2. Author contributions: All authors have accepted responsibility for the entire content of the manuscript and approved its submission.

  3. Competing interests: The authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study was designed to comply the criteria for ethical conduct and was approved by the Health Research Ethics Committee of Dr. Soetomo General Hospital, with reference number 1121/KEPK/IV/2019.

References

[1] Shuman R, Schuster D, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med 1987;106:562–7.10.7326/0003-4819-106-4-562Suche in Google Scholar PubMed

[2] Buendgens L, Koch A, Tacke F. Prevention of stress-related ulcer bleeding at the intensive care unit: risks and benefits of stress ulcer prophylaxis. World J Crit Care Med 2016;5:57–64.10.5492/wjccm.v5.i1.57Suche in Google Scholar PubMed PubMed Central

[3] Barletta JF, Bruno JJ, Buckley MS, Cook DJ. Concise. Definitive review: stress ulcer prophylaxis. Crit Care Med 2016; 4 (7): 1395– 1405.10.1097/CCM.0000000000001872Suche in Google Scholar PubMed

[4] Guillamondegui OD, Gunter OL, Bonadies JA, Coates JE, Kurek SJ, De Moy MA, Sing RF, Alan J, Sori AJ. Practice management guidelines for stress ulcer prophylaxis. EAST Practice Management Guidelines Committee. Eastern Association for the Surgery of Trauma, 2008.Suche in Google Scholar

[5] Zeitoun A, Zeineddine M, Dimassi H. Stress ulcer prophylaxis guidelines: are they being implemented in Lebanese health care centers? World J Gastrointest Pharmacol Ther 2011;2:27–35.10.4292/wjgpt.v2.i4.27Suche in Google Scholar PubMed PubMed Central

[6] Schefold JC, Perner A, Lange T, Wetterslev J, Wise MP, Borthwick M, et al. Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): study protocol for a pre-planned observational study. Trials 2018;19:26.10.1186/s13063-017-2408-3Suche in Google Scholar PubMed PubMed Central

[7] Ye Z-K, Liu Y, Cui X-L, Liu L-H. Critical appraisal of the quality of clinical practice guidelines for stress ulcer prophylaxis. PLoS One 2016;11:e0155020.10.1371/journal.pone.0155020Suche in Google Scholar PubMed PubMed Central

[8] Heidelbaugh J, Inadomi J, Goldberg K. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol 2006;101:2200–5.10.1111/j.1572-0241.2006.00839.xSuche in Google Scholar PubMed

[9] Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 2010;16:e228–34.Suche in Google Scholar

[10] Perwaiz MK, Posner G, Hammoudeh F, Schmidt F, Neupane N, Enriquez D, et al. Inappropriate use of intravenous ppi for stress ulcer prophylaxis in an inner city community hospital. J Clin Med Res 2010;2:215–9.10.4021/jocmr447wSuche in Google Scholar

[11] Farrell CP, Mercogliano G, Kuntz CL. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care 2010;25:214–20.10.1016/j.jcrc.2009.05.014Suche in Google Scholar PubMed

[12] Singh A, Bodukam V, Saigal K, Bahl J, Wang Y, Hanlon A, Lu Yinghui, Davis Michael, et al. Indentifying risk factors associated with inappropriate use of acid suppressive theraphy at a community hospital. Gastroenterol Res Pract. 2016;2016:1–7. Article ID 1973086.10.1155/2016/1973086Suche in Google Scholar PubMed PubMed Central

[13] Chen P, Reddy N, Loesch E, Agrawal S. Appropriateness of stress ulcer prophylaxis in hospitalized patients. J Gastric Disord Ther 2016;2.10.16966/2381-8689.122Suche in Google Scholar

[14] Akshaya D, Sarala K, Sharmila R. A study of select determinants for hospital stay among surgical patients ina tertiary care hospital. Int J Manage Appl Sci 2016;2:37–43.Suche in Google Scholar

[15] Almeman A, Alkhoshaiban A, Rasool S. Prescribing practices and cost of drugs for peptic ulcer in a primary health center in Pulau Penang Malaysia. Trop J Pharm Res 2013;12:629–34.10.4314/tjpr.v12i4.28Suche in Google Scholar

[16] Kalinowski CP, Kirsch JR. Strategies for prophylaxis and treatment. Best Pract Res Clin Anaesthesiol 2004;18:719–37.10.1016/j.bpa.2004.05.008Suche in Google Scholar PubMed

[17] Syrigou E, Triantafyllou O, Makrilia N, Kaklamanos I, Kotanidou A, Manolopoulos L, et al. Acute hypersensitivity reactions to chemotherapy agents: an overview. Inflamm Allergy Drug Targets, 2010;9:206–13.10.2174/187152810792231887Suche in Google Scholar PubMed

[18] Sheikh-Taha M, Alaeddine S, Nassif J. Use of acid suppressive therapy in hospitalized non–critically ill patients. World J Gastrointest Pharmacol Ther 2012;3:93–6.10.4292/wjgpt.v3.i6.93Suche in Google Scholar PubMed PubMed Central

[19] Bez C, Perrottet N, Zingg T, Leung Ki EL, Demartines N, Pannatier A. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department. J Eval Clin Pract 2012;19:374–8.10.1111/j.1365-2753.2012.01838.xSuche in Google Scholar PubMed

[20] Goldstein J, Cryer B. Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and prevention strategies. Drug Health Patient Saf 2015;7:31–41.10.2147/DHPS.S71976Suche in Google Scholar PubMed PubMed Central

[21] Batlouni M. Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects. Arq Bras Cardiol 2010;94:556–63.10.1590/S0066-782X2010000400019Suche in Google Scholar PubMed

[22] Pisegna JR. Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition. Crit Care Med 2002;30:S356–61.10.1097/00003246-200206001-00003Suche in Google Scholar PubMed PubMed Central

[23] Abdi AM, Shah SS, Albaghdadi H, Basgut B. Rational drug use in stress ulcer prophylaxis at a tertiary hospital in Northern Cyprus. Int J Pharm Technol 2017;9:31047–58.Suche in Google Scholar

[24] Cook D, Guyatt G. Prophylaxis against upper gastrointestinal bleeding in hospitalized patients. N Engl J Med 2018;378:2506–16.10.1056/NEJMra1605507Suche in Google Scholar PubMed

[25] Anderson ME. Stress ulcer prophylaxis in hospitalized patients. Hos Med Clin. 2013;2:e32–e44.10.1016/j.ehmc.2012.07.004Suche in Google Scholar

[26] Deshpande S, Dessoky M, Brock P. Algorithm based management improves compliance with stress ulcer prophylaxis in ICU. J Anaesth Pract 2017.Suche in Google Scholar

[27] Roselló S, Blasco I, García Fabregat L, Cervantes A, Jordan K, ESMO Guidelines Committee. Management of infusion reactions to systemic anticancer therapy: ESMO clinical practice guidelines. Ann Oncol 2017;28:iv100–18.10.1093/annonc/mdx216Suche in Google Scholar PubMed

[28] Mohamad S, Shamsudin N, Tan KM. Appropriateness of stress ulcer prophylaxis among older adults admitted to general medical wards in a university hospital. Eur Geriatr Med 2015;6:119–23.10.1016/j.eurger.2014.11.004Suche in Google Scholar

[29] Verma P, Thakur AS, Deshmukh K, Jha AK, Verma S. Routes of drug administration. Int J Pharm Stud Res 2010;1:54–9.Suche in Google Scholar

[30] Cyriac JM, Emmanuel J. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother 2014;5:83–7.10.4103/0976-500X.130042Suche in Google Scholar PubMed PubMed Central

[31] Shin S. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review. Ther Clin Risk Manage 2015;11:649–57.10.2147/TCRM.S81759Suche in Google Scholar PubMed PubMed Central

Received: 2019-10-15
Accepted: 2019-11-20
Published Online: 2020-01-11

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
https://doi.org/10.1515/jbcpp-2019-0306
Schlagwörter für diesen Artikel
drug costs; overuse; stress ulcer; stress ulcer prophylaxis

Artikel in diesem Heft

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 29.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0306/html?lang=de
Button zum nach oben scrollen